811 episodes

Interviews with leading researchers and thinkers in health care about practice-changing research, innovations, and the most pressing issues facing medicine and health care today from JAMA, the Journal of the American Medical Association.

JAMA Author Interviews JAMA Network

    • Health & Fitness

Interviews with leading researchers and thinkers in health care about practice-changing research, innovations, and the most pressing issues facing medicine and health care today from JAMA, the Journal of the American Medical Association.

    Sudden Death, Calcium Release Deficiency Syndrome, and a New ECG Finding

    Sudden Death, Calcium Release Deficiency Syndrome, and a New ECG Finding

    Can a new ECG finding identify individuals at risk for dying suddenly? Jason D. Roberts, MD, of McMaster University joins JAMA Associate Editor Gregory M. Marcus, MD, MAS, to discuss A Clinical Diagnostic Test for Calcium Release Deficiency Syndrome (CRDS). CRDS is a recently described cause of sudden arrhythmic death. Until now, no clinical test has existed to identify those with the disease.

    Related Content:
    A Clinical Diagnostic Test for Calcium Release Deficiency Syndrome The First Clinical Test for Calcium Release Deficiency Syndrome?

    • 12 min
    Continuous vs Intermittent β-Lactam Antibiotic Infusions in Patients With Sepsis

    Continuous vs Intermittent β-Lactam Antibiotic Infusions in Patients With Sepsis

    Joel M. Dulhunty, MD, PhD, Royal Brisbane and Women’s Hospital, and Jason A. Roberts, BPharm, PhD, University of Queensland Centre for Clinical Research, join JAMA Deputy Editor Preeti Malani, MD, MSJ, to discuss the BLING trial that assessed continuous vs intermittent β-lactam antibiotic infusions in patients with sepsis or septic shock.

    Related Content:
    Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis Prolonged vs Intermittent Infusions of β-Lactam Antibiotics in Adults With Sepsis or Septic Shock

    • 9 min
    Integrating Clinical Trials With the Practice of Medicine

    Integrating Clinical Trials With the Practice of Medicine

    Randomized clinical trials (RCTs) frequently fail to generate knowledge relevant to practice, while practice patterns are frequently unsupported by RCT evidence. Derek C. Angus, MD, MPH, of the University of Pittsburgh, joins JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, to discuss The Integration of Clinical Trials With the Practice of Medicine: Repairing a House Divided.

    Related Content:
    The Integration of Clinical Trials With the Practice of Medicine

    • 18 min
    Evidence Against Nitrogen’s Use for the Death Penalty

    Evidence Against Nitrogen’s Use for the Death Penalty

    Forced nitrogen inhalation was used by the state of Alabama to execute Kenneth Smith on January 25, 2024. Some politicians, attorneys general, and health care practitioners support its use for capital punishment in the US. Philip E. Bickler, MD, PhD, and Michael S. Lipnick, MD, discuss the evidence indicating that forced nitrogen inhalation is inhumane with JAMA Executive Editor Gregory Curfman, MD.

    Related Content:
    Evidence Against Use of Nitrogen for the Death Penalty

    • 12 min
    Outcomes After Living Kidney Donation

    Outcomes After Living Kidney Donation

    Guidelines call for better evidence on the health outcomes after living kidney donation. Author Amit X. Garg, MD, PhD, London Health Sciences Centre, and editorialist Elizabeth C. Lorenz, MD, Baylor College of Medicine, discuss a new study that compares the risks of hypertension and other health outcomes in living kidney donors, with JAMA Associate Editor Wolfgang Winkelmayer, MD, ScD.

    Related Content:
    Hypertension and Kidney Function After Living Kidney Donation Prospectively Examining Outcomes After Living Kidney Donation Kidney Transplant Outcomes From Deceased Donors Who Received Dialysis Expanding the Overton Window in Deceased Kidney Donor Eligibility—Enough to Make a Difference?

    • 11 min
    Cardiac Amyloidosis and the V142I Transthyretin Variant

    Cardiac Amyloidosis and the V142I Transthyretin Variant

    What is the natural history and cardiovascular burden of the V142I transthyretin variant among US Black individuals who carry this variant? Senthil Selvaraj, MD, MS, MA, from Duke University, and Scott D. Solomon, MD, from Brigham and Women’s Hospital, discuss this and more with JAMA Executive Editor Gregory Curfman, MD.

    Related Content:
    Cardiovascular Burden of the V142I Transthyretin Variant Addressing Health Disparities—The Case for Variant Transthyretin Cardiac Amyloidosis Grows Stronger Heart Failure in African American Individuals, Version 2.0 Cardiac Amyloidosis Due to Transthyretin Protein

    • 13 min

Top Podcasts In Health & Fitness

HjerneRO
Mindcamp
Detox Din Hjerne
Morten Elsøe & Anne Gaardmand
ADHD Podcast med Manu Sareen
Manu Sareen, Podads
Min gåtur gennem livet
Hjerteforeningen
ENHED med Noell Elise
Noell Elise
Vores Mentale Sundhed - En Mind Care Collective Podcast
Lea Hellmann

You Might Also Like

JAMA Clinical Reviews
JAMA Network
JAMA Medical News
JAMA Network
JAMA Editors' Summary
JAMA Network
JAMAevidence JAMA Guide to Statistics and Methods
JAMA Network
NEJM This Week
NEJM Group
Annals On Call Podcast
American College of Physicians